BioSpace News Archive

Drug Development

Bayer Corporation’s Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone

June 6, 2011
·
4 min read
Drug Development

Teva Pharmaceutical Industries Limited Announces Successful Results of Phase III Study of Its Long-Acting G-CSF Product (Lipegfilgrastim) in Breast Cancer Patients

June 6, 2011
·
3 min read
Drug Development

Celator Pharmaceuticals, Inc. Presents Positive Data from Phase 2 Study of CPX-351 at the American Society of Clinical Oncology Meeting

June 6, 2011
·
5 min read
Drug Development

RXi Pharmaceuticals Announces Positive NeuVaxTM (E75) Phase 2 Efficacy Results After 36 Months of Follow-Up

June 6, 2011
·
6 min read
Business

Biomedical Advanced Research and Development Authority (BARDA) Exercises Options With Cangene Corporation Worth US$61 Million Under Botulism Antitoxin Supply Contract

June 6, 2011
·
5 min read
Pharm Country

Institute for Hepatitis and Virus Research Receives One of World’s Largest Natural Products Library from Merck & Co., Inc.

June 6, 2011
·
3 min read
BioMidwest

Express Scripts Inc. to Present at the William Blair 2011 Growth Stock Conference

June 6, 2011
·
1 min read
Pharm Country

Fujirebio Diagnostics, Inc. Release: New Publication Validates Use of HE4 in Evaluating Risk of Ovarian Cancer

June 6, 2011
·
4 min read
Drug Development

Astellas Pharma Inc. Announces New Study Results Showing Increased Survival Rate for Metastatic Pancreatic Cancer

June 6, 2011
·
3 min read
BioMidwest

Kendle International Commences Tender Offer and Consent Solicitation For Convertible Notes

June 6, 2011
·
6 min read